Myeloid Leukemia, Acute
10 clinical trials · Condition
◉ Watch Myeloid Leukemia, Acute
| Record | Firm | Date |
|---|---|---|
| Integrative "Omics" Approaches for Leukemia Target Identification and Matched Therapeutic Intervention (NCT06626893) | Azienda Ospedaliero-Universitaria di Parma | 2022-03-01 |
| Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe) (NCT04942730) | St. Petersburg State Pavlov Medical University | 2021-01-21 |
| Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies (NCT04943757) | St. Petersburg State Pavlov Medical University | 2021-01-21 |
| IS-free Treg HaploHCT (NCT04678401) | Dana-Farber Cancer Institute | 2021-01-12 |
| Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia (NCT02665065) | Actinium Pharmaceuticals | 2016-06-01 |
Track Myeloid Leukemia, Acute automatically
Every clearance here is in the API, with alerts when new ones post.